My shopping cart
Your cart is currently empty.Continue Shopping
Remdesivir is an antiviral medication that first emerged in 2009 for Ebola and Hepatitis C, a known pathogenic virus that infects the liver and can lead to serious organ damage. When Remdesivir failed to perform, it was shelved and put aside – until now. Today that has all changed.
The revival, reappearance and makeover of Remdesivir testify to the powerful role played by federal funding from we the taxpayers. Such grants are allowing researchers to continue their investigative efforts in the biology of disease and treatment.
The Remdesivir trial, sponsored by the National Institute of Allergy and Infectious Diseases, examined the drug in battling SARS-CoV-2. The study followed more than 1,000 patients hospitalized for Covid-19. The numbers revealed that patients receiving Remdesivir recovered faster than those given a placebo. This recovery rate improved from 15 days to a period of 11 days. However, for mortality rates, Remdesivir did not significantly reduce death from the virus.
PRESIDENT TRUMP'S OPINION: Trump hailed the drug on Friday as an "important treatment” and “really promising.”
DR. ANTHONY FAUCI'S OPINION: Fauci, director of the National Institute of Allergy and Infectious Diseases, said the results were “a very important proof of concept” but not a “knockout.”
“PROOF OF CONCEPT”: Who To Believe?
PROCEED WITH CAUTION: LATEST MODERNA VACCINATION CLAIMS
An expert in the field, warns us about unprecedented approval procedures.
Developing a new drug requires a great amount of research work in chemistry, manufacturing, controls, pre-clinical science and clinical trials. The research and development of "important" treatments are tedious and time-consuming. Usually such treatments require a diligent pursuit and even a lifetime of effort.
As of now, one of the popular strategies for COVID-19 therapy is antivirals that directly target critical stages in the viral life cycle, such as binding onto and entry of the virus into host cells, then the viral replication and packaging or releasing of viral progeny from target cells. Unfortunately, the difficulty of such strategies make finding a truly safe and significant pharmaceutical treatment quite daunting, particularly for individuals with a medical history of comorbidity, referring to people diagnosed with diseases or conditions such as diabetes, obesity or chronic respiratory illnesses.
PERSPECTIVE FROM A WOMAN’S VIEW: HOW DO WE PROTECT OUR FAMILY MEMBERS FROM AGRESSIVE PHARMACEUTICAL MARKETING?
With so much going on in the press and conflicting expert opinion, it’s a wise practice to do our own investigations, especially when it comes to a woman’s wellness and her family’s health and well-being. Many women are suspicious of big pharmaceutical companies notorious for pushing out blockbuster medications before their safety has been assured.
What is a realistic time frame for producing a drug that's safe and effective for everyone? Many researchers say creating a vaccination could take approximately two years to a lifetime of trails.
MOMS: CALL TO ARMS — KNOWLEDGE IS POWER!
While many physicians are optimistically embracing Remdesivir, women can do a lot by naturally strengthening their immune systems, cultivating a healthy immune response with bacterial flora, getting fit, losing weight and finding ways to reduce inflammation. Certainly, we all can do things like eating more veggies and cutting back on sugars.
There is plenty of literature that shows us how to do exactly that.
We just have to move forward and lead by example. During these uncertain times, knowledge is power.